
Timothy Patrick Whelan MD
Critical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine, Pleural Disease
Physician
Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Fax+1 843-792-1729
Dr. Whelan is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2003
University of ColoradoResidency, Internal Medicine, 1995 - 1998
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1995
Certifications & Licensure
SC State Medical License 2010 - 2027
MN State Medical License 2003 - 2010
WA State Medical License 2000 - 2005
CO State Medical License 1998 - 2001
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
Clinical Trials
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis Start of enrollment: 2016 May 26
- Hypofractionated LocoRegional Radiotherapy in Breast Cancer Start of enrollment: 2021 Feb 10
Publications & Presentations
PubMed
- 2 citationsExtent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry.Aparna C Swaminathan, Jeremy M Weber, Jamie L Todd, Scott M Palmer, Megan L Neely
Respiratory Research. 2025-02-28 - Impact of lung allocation policy change on Hispanic lung transplant outcomes: Addressing disparities and improving access.Eric Klipsch, Jeffrey Rodgers, Kelly Sokevitz, Jennie Kwon, Khaled Shorbaji
JTCVS Open. 2024-12-01 - 3 citationsA multidimensional classifier to support lung transplant referral in patients with pulmonary fibrosis.Janelle Vu Pugashetti, John S Kim, Michael P Combs, Shwu-Fan Ma, Ayodeji Adegunsoye
The Journal of Heart and Lung Transplantation. 2024-07-01
Press Mentions
Some Cancer Patients May Not Need Treatments After SurgeryJune 14th, 2022
Some Cancer Patients Can Skip Treatments, 2 Studies ShowJune 8th, 2022
Studies Pinpoint Which Patients Can Skip Cancer TreatmentsJune 7th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









